CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

Brian Kavanagh ¹, Shaun O'Brien , David Lee , Yafei Hou , Vivian Weinberg , Brian Rini , James P Allison , Eric J Small , Lawrence Fong

Affiliations

¹ Department of Microbiology and Immunology, Division of Hematology/Oncology, University of California, San Francisco, CA 94143, USA.

PMID: 18523152
53 References
113 citations

Abstract

Cytotoxic T lymphocyte-associated antigen 4 (CTLA4) delivers inhibitory signals to activated T cells. CTLA4 is constitutively expressed on regulatory CD4(+) T cells (Tregs), but its role in these cells remains unclear. CTLA4 blockade has been shown to induce antitumor immunity. In this study, we examined the effects of anti-CTLA4 antibody on the endogenous CD4(+) T cells in cancer patients. We show that CTLA4 blockade induces an increase not only in the number of activated effector CD4(+) T cells, but also in the number of CD4(+) FoxP3(+) Tregs. Although the effects were dose-dependent, CD4(+) FoxP3(+) regulatory T cells could be expanded at lower antibody doses. In contrast, expansion of effector T cells was seen only at the highest dose level studied. Moreover, these expanded CD4(+) FoxP3(+) regulatory T cells are induced to proliferate with treatment and possess suppressor function. Our results demonstrate that treatment with anti-CTLA4 antibody does not deplete human CD4(+) FoxP3(+) Tregs in vivo, but rather may mediate its effects through the activation of effector T cells. Our results also suggest that CTLA4 may inhibit Treg proliferation similar to its role on effector T cells. This study is registered at http://www.clinicaltrials.gov/ct2/show/NCT00064129, registry number NCT00064129.

Other Links

Free PMC article
Full text on Blood

References
Cited By

References
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. A van Elsas, R P Sutmuller, +8 authors, J P Allison. less J Exp Med, 2001 Aug 22; 194(4). PMID: 11514604 Free PMC article.
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer. Eric J Small, N Simon Tchekmedyian, +3 authors, James P Allison. less Clin Cancer Res, 2007 Mar 17; 13(6). PMID: 17363537 Highly Cited.
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. A van Elsas, A A Hurwitz, J P Allison. J Exp Med, 1999 Aug 03; 190(3). PMID: 10430624 Free PMC article. Highly Cited.
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Shimon Sakaguchi, Masahiro Ono, +6 authors, Takashi Nomura. less Immunol Rev, 2006 Aug 15; 212. PMID: 16903903 Highly Cited. Review.
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy. Antoni Ribas, John A Glaspy, +11 authors, Lisa H Butterfield. less J Immunother, 2004 Aug 18; 27(5). PMID: 15314544
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. Jens Dannull, Zhen Su, +8 authors, Johannes Vieweg. less J Clin Invest, 2005 Nov 26; 115(12). PMID: 16308572 Free PMC article. Highly Cited.
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. Peter Attia, Giao Q Phan, +14 authors, Steven A Rosenberg. less J Clin Oncol, 2005 Aug 10; 23(25). PMID: 16087944 Free PMC article. Highly Cited.
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Sameer A Siddiqui, Xavier Frigola, +13 authors, Eugene D Kwon. less Clin Cancer Res, 2007 Apr 04; 13(7). PMID: 17404089
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. Sergio A Quezada, Karl S Peggs, Michael A Curran, James P Allison. J Clin Invest, 2006 Jun 17; 116(7). PMID: 16778987 Free PMC article. Highly Cited.
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Sarah E Allan, Sarah Q Crome, +5 authors, Megan K Levings. less Int Immunol, 2007 Mar 03; 19(4). PMID: 17329235 Highly Cited.
Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. Ajay V Maker, Peter Attia, Steven A Rosenberg. J Immunol, 2005 Nov 23; 175(11). PMID: 16301685 Free PMC article.
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Udaya K Liyanage, Todd T Moore, +8 authors, David C Linehan. less J Immunol, 2002 Aug 24; 169(5). PMID: 12193750 Highly Cited.
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. T Takahashi, T Tagami, +5 authors, S Sakaguchi. less J Exp Med, 2000 Jul 19; 192(2). PMID: 10899917 Free PMC article. Highly Cited.
Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. Giovanni C Cesana, Gail DeRaffele, +7 authors, Howard L Kaufman. less J Clin Oncol, 2006 Mar 01; 24(7). PMID: 16505437
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Gang Zhou, Charles G Drake, Hyam I Levitsky. Blood, 2005 Sep 24; 107(2). PMID: 16179369 Free PMC article.
Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. R Schwarting, J Gerdes, +2 authors, J Niehus, L Jaeschke, H Stein. less J Immunol Methods, 1986 Jun 10; 90(1). PMID: 3711671
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Jason D Fontenot, Alexander Y Rudensky. Nat Immunol, 2005 Mar 24; 6(4). PMID: 15785758 Highly Cited. Review.
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Zhi-Zhang Yang, Anne J Novak, +2 authors, Mary J Stenson, Thomas E Witzig, Stephen M Ansell. less Blood, 2006 Jan 13; 107(9). PMID: 16403912 Free PMC article. Highly Cited.
Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. Xuan Duc Nguyen, Hermann Eichler, +3 authors, Harald Klüter. less J Immunol Methods, 2003 Apr 02; 275(1-2). PMID: 12667670
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. Kimberly E Beck, Joseph A Blansfield, +12 authors, James C Yang. less J Clin Oncol, 2006 May 20; 24(15). PMID: 16710025 Free PMC article. Highly Cited.
The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. Shimon Sakaguchi. J Clin Invest, 2003 Nov 05; 112(9). PMID: 14597756 Free PMC article.
CTLA-4 regulates induction of anergy in vivo. R J Greenwald, V A Boussiotis, +2 authors, R B Lorsbach, A K Abbas, A H Sharpe. less Immunity, 2001 Mar 10; 14(2). PMID: 11239447 Highly Cited.
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Shimon Sakaguchi. Nat Immunol, 2005 Mar 24; 6(4). PMID: 15785760 Highly Cited. Review.
CD4+ CD25+ suppressor T cells: more questions than answers. Ethan M Shevach. Nat Rev Immunol, 2002 Jul 03; 2(6). PMID: 12093005 Highly Cited. Review.
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Marc A Gavin, Troy R Torgerson, +7 authors, Alexander Y Rudensky. less Proc Natl Acad Sci U S A, 2006 Apr 18; 103(17). PMID: 16617117 Free PMC article. Highly Cited.
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. R P Sutmuller, L M van Duivenvoorde, +6 authors, C J Melief. less J Exp Med, 2001 Sep 19; 194(6). PMID: 11560997 Free PMC article. Highly Cited.
CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. Ashley M Miller, Kajsa Lundberg, +4 authors, Pavel Pisa. less J Immunol, 2006 Nov 04; 177(10). PMID: 17082659 Highly Cited.
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. F Stephen Hodi, Martin C Mihm, +14 authors, Glenn Dranoff. less Proc Natl Acad Sci U S A, 2003 Apr 17; 100(8). PMID: 12682289 Free PMC article. Highly Cited.
Foxp3 in control of the regulatory T cell lineage. Ye Zheng, Alexander Y Rudensky. Nat Immunol, 2007 Apr 19; 8(5). PMID: 17440451 Highly Cited. Review.
CD4+CD25high regulatory T cells in human autoimmune diabetes. Amy L Putnam, Francesco Vendrame, Francesco Dotta, Peter A Gottlieb. J Autoimmun, 2005 Feb 24; 24(1). PMID: 15725577
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Giao Q Phan, James C Yang, +14 authors, Steven A Rosenberg. less Proc Natl Acad Sci U S A, 2003 Jun 27; 100(14). PMID: 12826605 Free PMC article. Highly Cited.
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. Kristin Sanderson, Ronald Scotland, +9 authors, Jeffrey Weber. less J Clin Oncol, 2004 Dec 23; 23(4). PMID: 15613700
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. Mindi R Walker, Deborah J Kasprowicz, +4 authors, Steven F Ziegler. less J Clin Invest, 2003 Nov 05; 112(9). PMID: 14597769 Free PMC article. Highly Cited.
Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Pratip K Chattopadhyay, Joanne Yu, Mario Roederer. Nat Protoc, 2007 Apr 05; 1(1). PMID: 17406204
CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. A A Hurwitz, T F Yu, D R Leach, J P Allison. Proc Natl Acad Sci U S A, 1998 Aug 26; 95(17). PMID: 9707601 Free PMC article. Highly Cited.
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Deirdre O'Mahony, John C Morris, +16 authors, John E Janik. less Clin Cancer Res, 2007 Feb 10; 13(3). PMID: 17289891
Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. A Caruso, S Licenziati, +8 authors, A Turano. less Cytometry, 1997 Jan 01; 27(1). PMID: 9000587
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. S Read, V Malmström, F Powrie. J Exp Med, 2000 Jul 19; 192(2). PMID: 10899916 Free PMC article. Highly Cited.
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. N Sachsenberg, A S Perelson, +4 authors, L Perrin. less J Exp Med, 1998 May 23; 187(8). PMID: 9547340 Free PMC article. Highly Cited.
The B7 family revisited. Rebecca J Greenwald, Gordon J Freeman, Arlene H Sharpe. Annu Rev Immunol, 2005 Mar 18; 23. PMID: 15771580 Highly Cited. Review.
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Tyler J Curiel, George Coukos, +18 authors, Weiping Zou. less Nat Med, 2004 Aug 24; 10(9). PMID: 15322536 Highly Cited.
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. Manuelle Viguier, Fabrice Lemaître, +6 authors, Laurent Ferradini. less J Immunol, 2004 Jul 09; 173(2). PMID: 15240741 Highly Cited.
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. Hiroyoshi Nishikawa, Takuma Kato, +8 authors, Hiroshi Shiku. less J Exp Med, 2005 Mar 09; 201(5). PMID: 15753203 Free PMC article.
Regulatory T cells in immune surveillance and treatment of cancer. Tomoyuki Yamaguchi, Shimon Sakaguchi. Semin Cancer Biol, 2005 Dec 27; 16(2). PMID: 16376102 Review.
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. G J Bubley, M Carducci, +22 authors, G Wilding. less J Clin Oncol, 1999 Nov 05; 17(11). PMID: 10550143 Highly Cited.
Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. J Steitz, J Brück, +2 authors, J Lenz, J Knop, T Tüting. less Cancer Res, 2001 Dec 26; 61(24). PMID: 11751377
Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer. Hans J van der Vliet, Hans J J van der Vliet, +8 authors, Mark A Exley. less Clin Cancer Res, 2007 Apr 04; 13(7). PMID: 17404092
CTLA-4: new insights into its biological function and use in tumor immunotherapy. Jackson G Egen, Michael S Kuhns, James P Allison. Nat Immunol, 2002 Jun 28; 3(7). PMID: 12087419 Highly Cited. Review.
Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Dat Q Tran, Heather Ramsey, Ethan M Shevach. Blood, 2007 Jul 24; 110(8). PMID: 17644734 Free PMC article. Highly Cited.
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. M F Krummel, J P Allison. J Exp Med, 1996 Jun 01; 183(6). PMID: 8676074 Free PMC article. Highly Cited.
CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Lequn Li, Wayne R Godfrey, +4 authors, Vassiliki A Boussiotis. less Blood, 2005 Jul 16; 106(9). PMID: 16020508 Free PMC article.
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. Weihong Liu, Amy L Putnam, +11 authors, Jeffrey A Bluestone. less J Exp Med, 2006 Jul 05; 203(7). PMID: 16818678 Free PMC article. Highly Cited.
Regulatory T cells and mechanisms of immune system control. Anne O'Garra, Paulo Vieira. Nat Med, 2004 Aug 03; 10(8). PMID: 15286781 Highly Cited. Review.

Citedby
Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Johan Verhagen, Leona Gabrysová, +4 authors, David C Wraith. less Proc Natl Acad Sci U S A, 2009 Feb 17; 106(9). PMID: 19218450 Free PMC article.
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. Nobuhiro Nakamoto, Hyosun Cho, +8 authors, Kyong-Mi Chang. less PLoS Pathog, 2009 Feb 28; 5(2). PMID: 19247441 Free PMC article. Highly Cited.
An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. James M Kelley, Laura B Hughes, +17 authors, S Louis Bridges. less PLoS Genet, 2009 Mar 21; 5(3). PMID: 19300490 Free PMC article.
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. Erika von Euw, Thinle Chodon, +4 authors, Antoni Ribas. less J Transl Med, 2009 May 22; 7. PMID: 19457253 Free PMC article.
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. C Coquerelle, G Oldenhove, +6 authors, M Moser. less Gut, 2009 Jun 10; 58(10). PMID: 19505881 Free PMC article.
Immunotherapeutic strategies in kidney cancer--when TKIs are not enough. Swethajit Biswas, Tim Eisen. Nat Rev Clin Oncol, 2009 Jun 24; 6(8). PMID: 19546865 Review.
Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells. Alwi Shatry, Jackeline Chirinos, +2 authors, Michael A Gorin, Monica Jones, Robert B Levy. less Biol Blood Marrow Transplant, 2009 Sep 15; 15(10). PMID: 19747630 Free PMC article. Review.
Immunotherapy of cancer. Hossein Borghaei, Mitchell R Smith, Kerry S Campbell. Eur J Pharmacol, 2009 Oct 20; 625(1-3). PMID: 19837059 Free PMC article. Review.
Testing the theory of immune selection in cancers that break the rules of transplantation. Ariberto Fassati, N Avrion Mitchison. Cancer Immunol Immunother, 2009 Dec 25; 59(5). PMID: 20033157 Free PMC article. Review.
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy. Jianda Yuan, David B Page, +14 authors, Jedd D Wolchok. less Cancer Immun, 2010 Jan 08; 10. PMID: 20052966 Free PMC article.
T cell pathways involving CTLA4 contribute to a model of acute lung injury. Takeshi Nakajima, Carlos Jose Suarez, +6 authors, Patricia W Finn. less J Immunol, 2010 Apr 14; 184(10). PMID: 20385880 Free PMC article.
Immunotherapy for melanoma: current status and perspectives. Doru T Alexandrescu, Thomas E Ichim, +4 authors, Constantin A Dasanu. less J Immunother, 2010 Jun 17; 33(6). PMID: 20551839 Free PMC article. Review.
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells. Jiehua Zhou, Asad Bashey, +9 authors, Edward D Ball. less Biol Blood Marrow Transplant, 2010 Aug 18; 17(5). PMID: 20713164 Free PMC article.
T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics. Yael S Barach, Jun Sik Lee, Xingxing Zang. Trends Mol Med, 2010 Oct 26; 17(1). PMID: 20971039 Free PMC article. Review.
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Matteo Vergati, Vittore Cereda, +7 authors, Kwong Y Tsang. less Cancer Immunol Immunother, 2010 Oct 27; 60(2). PMID: 20976449 Free PMC article.
Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy. Margaret K Callahan, Jedd D Wolchok, James P Allison. Semin Oncol, 2010 Nov 16; 37(5). PMID: 21074063 Free PMC article. Review.
Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies. R Vermeij, N Leffers, +3 authors, H W Nijman. less J Biomed Biotechnol, 2011 May 05; 2011. PMID: 21541192 Free PMC article. Review.
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans. Rong Rong Huang, Jason Jalil, +10 authors, Antoni Ribas. less Clin Cancer Res, 2011 May 12; 17(12). PMID: 21558401 Free PMC article.
Prostate cancer immunotherapy. Kenneth F May, James L Gulley, +2 authors, Charles G Drake, Glenn Dranoff, Philip W Kantoff. less Clin Cancer Res, 2011 Jun 28; 17(16). PMID: 21700764 Free PMC article.
Immuno-therapy with anti-CTLA4 antibodies in tolerized and non-tolerized mouse tumor models. Jonas Persson, Ines Beyer, +4 authors, André Lieber. less PLoS One, 2011 Jul 23; 6(7). PMID: 21779410 Free PMC article.
Higher proportions of circulating FOXP3+ and CTLA-4+ regulatory T cells are associated with lower fractions of memory CD4+ T cells in infants. Hardis Rabe, Anna-Carin Lundell, +3 authors, Anna Rudin. less J Leukoc Biol, 2011 Sep 22; 90(6). PMID: 21934066 Free PMC article.
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Lucy S K Walker, David M Sansom. Nat Rev Immunol, 2011 Nov 26; 11(12). PMID: 22116087 Highly Cited.
Targeting regulatory T cells. Christine Ménétrier-Caux, Tyler Curiel, +3 authors, Weiping Zou. less Target Oncol, 2012 Feb 14; 7(1). PMID: 22327882 Review.
Unmasking the immune recognition of prostate cancer with CTLA4 blockade. Serena S Kwek, Edward Cha, Lawrence Fong. Nat Rev Cancer, 2012 Mar 02; 12(4). PMID: 22378189 Free PMC article. Review.
T-regulatory cells: key players in tumor immune escape and angiogenesis. Andrea Facciabene, Gregory T Motz, George Coukos. Cancer Res, 2012 May 03; 72(9). PMID: 22549946 Free PMC article. Highly Cited. Review.
Towards curative cancer immunotherapy: overcoming posttherapy tumor escape. Gang Zhou, Hyam Levitsky. Clin Dev Immunol, 2012 Jul 11; 2012. PMID: 22778760 Free PMC article. Review.
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination. Ahmad A Tarhini, Lisa H Butterfield, +3 authors, John M Kirkwood. less J Immunother, 2012 Oct 24; 35(9). PMID: 23090079 Free PMC article.
Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. Brian M Olson, Ewa Jankowska-Gan, +3 authors, Douglas G McNeel. less J Immunol, 2012 Nov 16; 189(12). PMID: 23152566 Free PMC article.
Primary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulation. Calvin Wei, Sasis Sirikanjanapong, +4 authors, Beverly Y Wang. less Ear Nose Throat J, 2013 Jan 29; 92(1). PMID: 23354891 Free PMC article.
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer. Satoshi Wada, Christopher M Jackson, +10 authors, Charles G Drake. less J Transl Med, 2013 Apr 06; 11. PMID: 23557194 Free PMC article.
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production. Stefania Laurent, Paola Queirolo, +15 authors, Maria Pia Pistillo. less J Transl Med, 2013 May 03; 11. PMID: 23634660 Free PMC article.
Monitoring regulatory immune responses in tumor immunotherapy clinical trials. Brian M Olson, Douglas G McNeel. Front Oncol, 2013 May 09; 3. PMID: 23653893 Free PMC article.
Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics. James H Finke, Pat A Rayman, +3 authors, Peter A Cohen. less Cancer J, 2013 Jul 23; 19(4). PMID: 23867518 Free PMC article. Review.
Therapeutic cancer vaccines: past, present, and future. Chunqing Guo, Masoud H Manjili, +3 authors, Xiang-Yang Wang. less Adv Cancer Res, 2013 Jul 23; 119. PMID: 23870514 Free PMC article. Highly Cited. Review.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
Specific recruitment of γδ regulatory T cells in human breast cancer. Jian Ye, Chunling Ma, +9 authors, Guangyong Peng. less Cancer Res, 2013 Aug 21; 73(20). PMID: 23959855 Free PMC article.
Current status of interleukin-10 and regulatory T-cells in cancer. Kristen L Dennis, Nichole R Blatner, Fotini Gounari, Khashayarsha Khazaie. Curr Opin Oncol, 2013 Oct 01; 25(6). PMID: 24076584 Free PMC article. Highly Cited. Review.
OX40 is a potent immune-stimulating target in late-stage cancer patients. Brendan D Curti, Magdalena Kovacsovics-Bankowski, +20 authors, Andrew D Weinberg. less Cancer Res, 2013 Nov 02; 73(24). PMID: 24177180 Free PMC article. Highly Cited.
Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer. Jo A Tucker, Caroline Jochems, +2 authors, James L Gulley, Jeffrey Schlom, Kwong Y Tsang. less Cancers (Basel), 2012 Jan 01; 4(4). PMID: 24213509 Free PMC article.
CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Lidia Robert, Jennifer Tsoi, +11 authors, Antoni Ribas. less Clin Cancer Res, 2014 Mar 04; 20(9). PMID: 24583799 Free PMC article. Highly Cited.
Down-regulation of MFG-E8 by RNA interference combined with doxorubicin triggers melanoma destruction. Jing-Yi Zhao, Xue-Lei Ma, +7 authors, Yu-Quan Wei. less Clin Exp Med, 2014 Mar 13; 15(2). PMID: 24619299
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo. Linda C Sandin, Fredrik Eriksson, +3 authors, Sara M Mangsbo. less Oncoimmunology, 2014 Apr 05; 3(1). PMID: 24701377 Free PMC article.
Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs. Kesley Attridge, Lucy S K Walker. Immunol Rev, 2014 Apr 10; 259(1). PMID: 24712457 Free PMC article. Review.
Gut microbiota and the paradox of cancer immunotherapy. Theofilos Poutahidis, Markus Kleinewietfeld, Susan E Erdman. Front Immunol, 2014 Apr 30; 5. PMID: 24778636 Free PMC article. Review.
Regulatory T cells-an important target for cancer immunotherapy. Jae Il Shin, Sang-Jun Ha. Nat Rev Clin Oncol, 2014 May 02; 11(6). PMID: 24781417
Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Edward Cha, Mark Klinger, +4 authors, Lawrence Fong. less Sci Transl Med, 2014 May 30; 6(238). PMID: 24871131 Free PMC article. Highly Cited.
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells. Hiroshi Yano, Archana Thakur, +3 authors, Lawrence G Lum. less J Transl Med, 2014 Jul 11; 12. PMID: 25008236 Free PMC article.
TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence. Jian Ye, Chunling Ma, +9 authors, Guangyong Peng. less EMBO Mol Med, 2014 Sep 19; 6(10). PMID: 25231413 Free PMC article.
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Dalil Hannani, Marie Vétizou, +30 authors, Laurence Zitvogel. less Cell Res, 2015 Jan 15; 25(2). PMID: 25582080 Free PMC article. Highly Cited.
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. Stefanie N Linch, Michael J McNamara, William L Redmond. Front Oncol, 2015 Mar 13; 5. PMID: 25763356 Free PMC article. Highly Cited. Review.
Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab. Serena S Kwek, Jera Lewis, +7 authors, Lawrence Fong. less Cancer Immunol Res, 2015 May 15; 3(9). PMID: 25968455 Free PMC article.
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. Saskia J A M Santegoets, Eveline M Dijkgraaf, +15 authors, Sjoerd H van der Burg. less Cancer Immunol Immunother, 2015 Jul 01; 64(10). PMID: 26122357 Free PMC article. Highly Cited.
Combination cancer immunotherapies tailored to the tumour microenvironment. Mark J Smyth, Shin Foong Ngiow, Antoni Ribas, Michele W L Teng. Nat Rev Clin Oncol, 2015 Nov 26; 13(3). PMID: 26598942 Highly Cited. Review.
Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Jianda Yuan, Priti S Hegde, +16 authors, Bernard A Fox. less J Immunother Cancer, 2016 Jan 21; 4. PMID: 26788324 Free PMC article. Highly Cited. Review.
Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints. Maria Alsina, Markus Moehler, +2 authors, Cinta Hierro, Raquel Guardeño, Josep Tabernero. less Target Oncol, 2016 Feb 18; 11(4). PMID: 26880697 Review.
Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab. Janet Retseck, Robert VanderWeele, +3 authors, Ahmad A Tarhini. less J Immunother Cancer, 2016 Jun 23; 4. PMID: 27330811 Free PMC article.
The role of regulatory T cells in cancer immunology. Theresa L Whiteside. Immunotargets Ther, 2015 Jan 01; 4. PMID: 27471721 Free PMC article. Review.
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Belal Chaudhary, Eyad Elkord. Vaccines (Basel), 2016 Aug 12; 4(3). PMID: 27509527 Free PMC article. Highly Cited. Review.
Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors. Soumaya Karaki, Marie Anson, +4 authors, Eric Tartour. less Vaccines (Basel), 2016 Nov 10; 4(4). PMID: 27827885 Free PMC article. Review.
Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs. Stephanie Du Four, Sarah K Maenhout, +3 authors, Joeri L Aerts. less Am J Cancer Res, 2016 Dec 03; 6(11). PMID: 27904768 Free PMC article.
TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis. Michael P Holt, George A Punkosdy, Deborah D Glass, Ethan M Shevach. J Immunol, 2017 Jan 06; 198(4). PMID: 28053234 Free PMC article.
Immunoregulatory functions of VISTA. Elizabeth C Nowak, J Louise Lines, +7 authors, Randolph J Noelle. less Immunol Rev, 2017 Mar 05; 276(1). PMID: 28258694 Free PMC article. Highly Cited. Review.
Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy. David M Francis, Susan N Thomas. Adv Drug Deliv Rev, 2017 Apr 30; 114. PMID: 28455187 Free PMC article. Review.
Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy. Jingyu Zhang, Dai Liu, +4 authors, Jennifer D Wu. less Sci Adv, 2017 Jun 01; 3(5). PMID: 28560327 Free PMC article.
Ibrutinib treatment improves T cell number and function in CLL patients. Meixiao Long, Kyle Beckwith, +17 authors, John C Byrd. less J Clin Invest, 2017 Jul 18; 127(8). PMID: 28714866 Free PMC article. Highly Cited.
Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults. Rawad Elias, Joshua Morales, Carolyn Presley. Curr Oncol Rep, 2017 Jul 30; 19(9). PMID: 28755314 Review.
Targets for immunotherapy of liver cancer. Tim F Greten, Bruno Sangro. J Hepatol, 2017 Sep 20;. PMID: 28923358 Free PMC article. Review.
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity. Pearl Bakhru, Meng-Lei Zhu, +14 authors, Maureen A Su. less JCI Insight, 2017 Sep 22; 2(18). PMID: 28931755 Free PMC article.
Checkpoint Inhibitors: Applications for Autoimmunity. Anna S Tocheva, Adam Mor. Curr Allergy Asthma Rep, 2017 Sep 29; 17(10). PMID: 28956259 Free PMC article. Review.
Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition. Xia Liu, Wei Mo, +5 authors, Guangyong Peng. less Nat Commun, 2018 Jan 18; 9(1). PMID: 29339767 Free PMC article.
Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells. Gap Ryol Lee. Mediators Inflamm, 2018 Feb 22; 2017. PMID: 29463952 Free PMC article. Review.
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Rajani Ravi, Kimberly A Noonan, +13 authors, Atul Bedi. less Nat Commun, 2018 Feb 23; 9(1). PMID: 29467463 Free PMC article. Highly Cited.
Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment. Antje Tunger, Maximilian Kießler, +4 authors, Marc Schmitz. less Biomedicines, 2018 Mar 02; 6(1). PMID: 29494517 Free PMC article. Review.
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Lee-Shing Chang, Romualdo Barroso-Sousa, +3 authors, Le Min. less Endocr Rev, 2018 Sep 06; 40(1). PMID: 30184160 Free PMC article. Review.
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? Andrew B Nixon, Kurt A Schalper, +3 authors, Catherine Fleener. less J Immunother Cancer, 2019 Nov 30; 7(1). PMID: 31775882 Free PMC article. Review.
T-Regulatory Cells In Tumor Progression And Therapy. Amit Verma, Rohit Mathur, +3 authors, Bilikere S Dwarakanath. less Cancer Manag Res, 2020 Jan 11; 11. PMID: 31920383 Free PMC article. Review.
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control. Emilio Sanseviero, Erin M O'Brien, +16 authors, Erica L Stone. less Cancer Immunol Res, 2019 Jun 27; 7(8). PMID: 31239316 Free PMC article.
Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms and biliary atresia susceptibility in Chinese children. Jia Liu, Yifan Yang, +6 authors, Shan Zheng. less Int J Clin Exp Pathol, 2018 May 01; 11(5). PMID: 31938405 Free PMC article.
Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors. Nicholas Gravbrot, Kacy Gilbert-Gard, +4 authors, Srinath Sundararajan. less Antibodies (Basel), 2019 Oct 24; 8(4). PMID: 31640266 Free PMC article. Review.
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy. Emily J Lelliott, Carleen Cullinane, +14 authors, Karen E Sheppard. less Sci Rep, 2019 Feb 06; 9(1). PMID: 30718660 Free PMC article.
Resistance to Checkpoint Inhibition in Cancer Immunotherapy. Luisa Barrueto, Francheska Caminero, +3 authors, Rahul R Deshmukh. less Transl Oncol, 2020 Mar 03; 13(3). PMID: 32114384 Free PMC article. Review.
CTLA-4: a moving target in immunotherapy. Behzad Rowshanravan, Neil Halliday, David M Sansom. Blood, 2017 Nov 10; 131(1). PMID: 29118008 Free PMC article. Highly Cited. Review.
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers. Anu Sharma, Sumit K Subudhi, +6 authors, Padmanee Sharma. less Clin Cancer Res, 2018 Jul 29; 25(4). PMID: 30054281 Free PMC article. Highly Cited.
An adapted anti-CTLA4 therapeutic aimed at mitigating the toxicities of checkpoint inhibition. Jarushka Naidoo, Arbor Dykema, Franco D'Alessio. J Clin Invest, 2018 Dec 12; 129(1). PMID: 30530990 Free PMC article.
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity. Chien-Chun Steven Pai, Donald M Simons, +22 authors, Lawrence Fong. less J Clin Invest, 2018 Dec 12; 129(1). PMID: 30530991 Free PMC article.
Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy. Hongwei Chen, Xin Luan, +7 authors, Duxin Sun. less Nanomedicine (Lond), 2019 Dec 24; 15(1). PMID: 31868112 Free PMC article.
Development of immune checkpoint therapy for cancer. Jill M Fritz, Michael J Lenardo. J Exp Med, 2019 May 10; 216(6). PMID: 31068379 Free PMC article. Highly Cited. Review.
Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised. A Charlotte M T de Wolf, Carla A Herberts, Marcel H N Hoefnagel. Front Med (Lausanne), 2020 Apr 18; 7. PMID: 32300597 Free PMC article. Systematic Review.
T cell costimulation, checkpoint inhibitors and anti-tumor therapy. Dipankar Nandi, Sanmoy Pathak, +6 authors, Vijayamahantesh. less J Biosci, 2020 Apr 30; 45. PMID: 32345776 Review.
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Rodolfo Daniel Cervantes-Villagrana, Damaris Albores-García, Alberto Rafael Cervantes-Villagrana, Sara Judit García-Acevez. Signal Transduct Target Ther, 2020 Jun 20; 5(1). PMID: 32555170 Free PMC article. Review.
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. David Y Oh, Serena S Kwek, +17 authors, Lawrence Fong. less Cell, 2020 Jun 05; 181(7). PMID: 32497499 Free PMC article.
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors. Diwakar Davar, Hassane M Zarour. Methods Mol Biol, 2019 Sep 11; 2055. PMID: 31502146 Free PMC article. Review.
Scientifically based combination therapies with immuno-oncology checkpoint inhibitors. Hui Yi Chew, Riccardo Dolcetti, Fiona Simpson. Br J Clin Pharmacol, 2020 May 07; 86(9). PMID: 32372470 Free PMC article. Review.
Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective? Liyan Li, Shudong Liu, Junxia Yu. Ther Adv Endocrinol Metab, 2020 Sep 26; 11. PMID: 32973994 Free PMC article. Review.
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Sujin Kang, Sooyeun Lee, Soyeun Park. Polymers (Basel), 2020 Aug 28; 12(9). PMID: 32847045 Free PMC article. Review.
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions. Guoming Zeng, Libo Jin, +9 authors, Da Sun. less Cancer Manag Res, 2020 Oct 30; 12. PMID: 33116895 Free PMC article. Review.
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies? Negar Hosseinkhani, Afshin Derakhshani, +9 authors, Behzad Baradaran. less Int J Mol Sci, 2020 Nov 11; 21(21). PMID: 33167514 Free PMC article. Review.
Ipilimumab in prostate cancer. Nishith Singh, Ravi A Madan, James L Gulley. Expert Opin Biol Ther, 2012 Dec 26; 13(2). PMID: 23265575 Free PMC article. Review.
Anti-CTLA-4 monoclonal antibody improves efficacy of the glyceraldehyde-3-phosphate dehydrogenase protein vaccine against Schistosoma japonicum in mice. Chun-Lian Tang, Jin-Feng Yang, +4 authors, Hong-Hua Zhou. less Parasitol Res, 2019 Jun 07; 118(7). PMID: 31168702
Modulation of regulatory T cell function and stability by co-inhibitory receptors. Liliana E Lucca, Margarita Dominguez-Villar. Nat Rev Immunol, 2020 Apr 10; 20(11). PMID: 32269380 Review.
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity. Allan Relecom, Maysaloun Merhi, +4 authors, Said Dermime. less J Exp Clin Cancer Res, 2021 Feb 20; 40(1). PMID: 33602280 Free PMC article. Review.
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer. Kristina Witt, Susan Evans-Axelsson, +3 authors, Rebecka Hellsten. less Cancer Immunol Immunother, 2021 Apr 01; 70(11). PMID: 33786638 Free PMC article.
Immunotherapy and predictive immunologic profile: the tip of the iceberg. Tatiana Cunha Pereira, Paulo Rodrigues-Santos, +7 authors, Gabriela Sousa. less Med Oncol, 2021 Apr 01; 38(5). PMID: 33788049 Review.
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer. Jacob Stultz, Lawrence Fong. Prostate Cancer Prostatic Dis, 2021 Apr 07; 24(3). PMID: 33820953 Free PMC article. Review.
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Navid Sobhani, Dana Rae Tardiel-Cyril, +3 authors, Yong Li. less Cancers (Basel), 2021 Apr 04; 13(6). PMID: 33809974 Free PMC article. Review.
Inhibition of acid sphingomyelinase increases regulatory T cells in humans. Teresa Wiese, Fabio Dennstädt, +16 authors, Niklas Beyersdorf. less Brain Commun, 2021 Apr 27; 3(2). PMID: 33898989 Free PMC article.
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer. Meenal Sinha, Li Zhang, +14 authors, Lawrence Fong. less J Immunother Cancer, 2021 May 15; 9(5). PMID: 33986125 Free PMC article.
Miscell: An efficient self-supervised learning approach for dissecting single-cell transcriptome. Hongru Shen, Yang Li, +13 authors, Xiangchun Li. less iScience, 2021 Oct 30; 24(11). PMID: 34712916 Free PMC article.
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Golnaz Morad, Beth A Helmink, Padmanee Sharma, Jennifer A Wargo. Cell, 2021 Oct 09; 184(21). PMID: 34624224 Free PMC article. Review.
Research Progress and Prospects for Polymeric Nanovesicles in Anticancer Drug Delivery. Dan Li, Xi Zhang, Xiao Chen, Wei Li. Front Bioeng Biotechnol, 2022 Mar 01; 10. PMID: 35223804 Free PMC article. Review.
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Alexander C Huang, Roberta Zappasodi. Nat Immunol, 2022 Mar 05; 23(5). PMID: 35241833 Free PMC article. Review.
Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy. Megan M Y Hong, Saman Maleki Vareki. Cancers (Basel), 2022 Mar 26; 14(6). PMID: 35326731 Free PMC article. Review.
Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors. Chen Wei, Mengyu Wang, +8 authors, Ning Li. less Cancer Immunol Immunother, 2022 Jun 07;. PMID: 35661905

BioKDE: Biomedical Knowledge Discovery Engine

Abstract

Other Links